138 related articles for article (PubMed ID: 2410329)
1. Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinoma.
Bast RC; Siegal FP; Runowicz C; Klug TL; Zurawski VR; Schonholz D; Cohen CJ; Knapp RC
Gynecol Oncol; 1985 Sep; 22(1):115-20. PubMed ID: 2410329
[TBL] [Abstract][Full Text] [Related]
2. The clinical significance of pre-operative serum CA 125 in ovarian cancer.
Cruickshank DJ; Fullerton WT; Klopper A
Br J Obstet Gynaecol; 1987 Jul; 94(7):692-5. PubMed ID: 2441738
[TBL] [Abstract][Full Text] [Related]
3. Tumor antigen CA 125 as a marker of ovarian epithelial carcinoma.
Zanaboni F; Vergadoro F; Presti M; Gallotti P; Lombardi F; Bolis G
Gynecol Oncol; 1987 Sep; 28(1):61-7. PubMed ID: 2443433
[TBL] [Abstract][Full Text] [Related]
4. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer.
Einhorn N; Bast RC; Knapp RC; Tjernberg B; Zurawski VR
Obstet Gynecol; 1986 Mar; 67(3):414-6. PubMed ID: 2418395
[TBL] [Abstract][Full Text] [Related]
5. CA 125 in gynecologic practice.
Malkasian GD; Podratz KC; Stanhope CR; Ritts RE; Zurawski VR
Am J Obstet Gynecol; 1986 Sep; 155(3):515-8. PubMed ID: 2428248
[TBL] [Abstract][Full Text] [Related]
6. CA 125 and TPA as markers in ovarian carcinoma.
Rodenburg CJ; De Maaker GA; Trimbos JB; Moolenaar AJ; Van Oosterom AT
Neth J Med; 1985; 28(12):536-40. PubMed ID: 2418375
[No Abstract] [Full Text] [Related]
7. [A monoclonal antibody RIA as an antigenic determinant (CA 125) in ovarian cancer patients].
Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 1985 Sep; 20(5):257-60, 317. PubMed ID: 2417787
[No Abstract] [Full Text] [Related]
8. [Experiences with CA 125, a tumor marker for malignant epithelial ovarian tumors].
Crombach G; Zippel HH; Würz H
Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):205-12. PubMed ID: 2408962
[TBL] [Abstract][Full Text] [Related]
9. CA-125: An evaluation.
Nuss R; Swor MG; Benrubi MD
J Fla Med Assoc; 1987 May; 74(5):329-32. PubMed ID: 2440975
[No Abstract] [Full Text] [Related]
10. A study of the NB/7OK and CA 125 monoclonal antibody radioimmunoassays for measuring serum antigen levels in ovarian cancer patients.
Knauf S; Anderson DJ; Knapp RC; Bast RC
Am J Obstet Gynecol; 1985 Aug; 152(7 Pt 1):911-3. PubMed ID: 2411137
[TBL] [Abstract][Full Text] [Related]
11. An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma.
Zurawski VR; Knapp RC; Einhorn N; Kenemans P; Mortel R; Ohmi K; Bast RC; Ritts RE; Malkasian G
Gynecol Oncol; 1988 May; 30(1):7-14. PubMed ID: 2452773
[TBL] [Abstract][Full Text] [Related]
12. Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma.
Sekine H; Hayes DF; Ohno T; Keefe KA; Schaetzl E; Bast RC; Knapp R; Kufe DW
J Clin Oncol; 1985 Oct; 3(10):1355-63. PubMed ID: 2413181
[TBL] [Abstract][Full Text] [Related]
13. Serum copper in ovarian carcinoma.
Jacobs AJ; Sommers GM; Axelrod JH; Galakatos AE; Kao MS; Camel HM
Cancer; 1988 Mar; 61(5):1015-7. PubMed ID: 3422179
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of serum CA 125 levels in the monitoring of ovarian cancer.
Vergote IB; Børmer OP; Abeler VM
Am J Obstet Gynecol; 1987 Jul; 157(1):88-92. PubMed ID: 2440307
[TBL] [Abstract][Full Text] [Related]
15. CA-125 in gynecological malignancies.
Meier W; Stieber P; Fateh-Moghadam A; Eiermann W; Hepp H
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):713-7. PubMed ID: 2443359
[TBL] [Abstract][Full Text] [Related]
16. Tumour-associated antigen CA 125 in patients with ovarian cancer.
Heinonen PK; Tontti K; Koivula T; Pystynen P
Br J Obstet Gynaecol; 1985 May; 92(5):528-31. PubMed ID: 3857939
[TBL] [Abstract][Full Text] [Related]
17. Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant disease.
Malkasian GD; Knapp RC; Lavin PT; Zurawski VR; Podratz KC; Stanhope CR; Mortel R; Berek JS; Bast RC; Ritts RE
Am J Obstet Gynecol; 1988 Aug; 159(2):341-6. PubMed ID: 2457318
[TBL] [Abstract][Full Text] [Related]
18. Comparative measurement of ovarian carcinoma antigen and carcinoembryonic antigen in the serum of ovarian cancer.
Yuan CC; Ng HT; Tsai LC; Jeng FS; Yeh SH; Tsai YC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):190-7. PubMed ID: 3480793
[TBL] [Abstract][Full Text] [Related]
19. The role of cancer antigen 125 (CA 125) in the management of ovarian epithelial carcinomas.
Altaras MM; Goldberg GL; Levin W; Bloch B; Darge L; Smith JA
Gynecol Oncol; 1988 May; 30(1):26-34. PubMed ID: 2452770
[TBL] [Abstract][Full Text] [Related]
20. CA 125 for the monitoring of ovarian carcinoma during primary therapy.
Lavin PT; Knapp RC; Malkasian G; Whitney CW; Berek JC; Bast RC
Obstet Gynecol; 1987 Feb; 69(2):223-7. PubMed ID: 2433652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
